Novel oral anticoagulant use in adult Fontan patients: A single center experience-Reference-Cited by-同舟云学术

Novel oral anticoagulant use in adult Fontan patients: A single center experience

Published:2018-03-24 Issue:4 Volume:13 Page:541-547
ISSN:1747-079X
Container-title:Congenital Heart Disease
language:en
Short-container-title:Congenital Heart Disease

Author:

Georgekutty Justin¹,Kazerouninia Amir²^ORCID,Wang YunFei³,Ermis Peter R.⁴,Parekh Dhaval R.⁴,Franklin Wayne J.⁴,Lam Wilson W.⁴

Affiliation:

1. Division of Pediatric Cardiology; Cohen Children's Medical Center/Northwell Health; New Hyde Park New York USA

2. Department of Internal Medicine/Department of Pediatrics; Baylor College of Medicine; Houston Texas USA

3. Section of Pediatric Cardiology, Texas Children's Hospital/Baylor College of Medicine; Houston Texas USA

4. Division of Adult Congenital Cardiology, Texas Children's Hospital/Baylor College of Medicine; Houston Texas USA

Publisher

Computers, Materials and Continua (Tech Science Press)

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine,Surgery,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/chd.12603/fullpdf

Reference35 articles.

1. Thromboembolism and the role of anticoagulation in the Fontan patient;Jacobs;Pediatr Cardiol.,2007

2. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD);Khairy;Heart Rhythm.,2014

3. Thrombosis and thromboembolic complications in fontan patients: a literature review;Firdouse;Clin Appl Thromb Hemost.,2014

4. Antiplatelet versus anticoagulation therapy after extracardiac conduit Fontan: a systematic review and meta-analysis;Marrone;Pediatr Cardiol.,2011

5. Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure;McCrindle;J Am Coll Cardiol.,2013

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management for atrial arrhythmias in adults with complex congenital heart disease;Expert Review of Cardiovascular Therapy;2023-06-01

2. Antiplatelet Versus Anticoagulation Treatment in Patients With Fontan Operation: A Systematic Review and Meta-Analysis;Cardiology in Review;2023-05-19

3. Thromboembolic Complications in Adult Patients Following Fontan Procedure—A Multicenter Study;Journal of Clinical Medicine;2023-05-14

4. Novel oral anticoagulant use in adults with congenital heart disease: a single-center experience report;The Egyptian Heart Journal;2023-01-10

5. Anticoagulation Strategies in the Single Ventricle;Univentricular Congenital Heart Defects and the Fontan Circulation;2023